FDA readies launch of quality metrics
FDA expects to start collecting quality metrics data from biopharmaceutical manufacturers at the beginning of next year to help it assess how well a firm can measure key elements of a quality drug production operation. The agency's current plan is to launch the initiative in January 2018 by opening an electronic portal that will accept metrics data for 2017. FDA staffers will keep the portal open for three months and then will evaluate and compare the data and issue a report later in the year.
Turmeric bioavailability enhancer could be used with APIs, Wacker
Wacker Biosolutions says an excipient shown to increase the bioavailability of a food supplement by a factor of 40 could have implications in the API space.
ExcipientFest Americas showcases pharma and biotech breakthroughs
Pharmaceutical and Biotech sciences are constantly amazing both patients and doctors with drugs and delivery methods that seem to be out of fiction movies. It is hard to believe that innovations like 3D printing of drugs, traceable protein biomaterials, marijuana-based new cures, and sugarless taste masking are real, and all of them will be discussed during ExcipientFest Americas, along with the latest pharmaceutical regulatory updates and sourcing solutions affecting the global marketplace on 25-26 April in Providence, Rhode Island.
Increasing efforts to innovate production techniques fosters growth prospects of global pharmaceutical excipients market
The burgeoning demand for functional excipients, owing to their extensive use in advanced drug delivery, is providing a significant boost to the growth of the global pharmaceutical excipients market. Moreover, several players, with the help of latest technologies, are focusing towards innovating techniques used in the production of excipients. This, in turn, is working in favor of the market. Continuous advancements in nanotechnology and biotechnology are also augmenting the global market.